We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Graft Polymer (uk) Plc | LSE:GPL | London | Ordinary Share | GB00BMD1Z199 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.005 | 2.44% | 0.21 | 0.20 | 0.22 | 0.21 | 0.205 | 0.21 | 9,900,763 | 08:21:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 587k | -3.12M | -0.0014 | -1.50 | 4.71M |
Date | Subject | Author | Discuss |
---|---|---|---|
26/9/2024 12:48 | Ticking back up | smackeraim | |
26/9/2024 09:21 | Dennis Purcell commented: "I am thrilled to join Graft Polymer's Board at such an exciting juncture. The Company's collaboration model, starting with Awakn, is poised to make a significant impact in the biopharmaceutical sector - specifically in the area of treating addiction and mental health issues, where there is an enormous opportunity. I look forward to working closely with my fellow Board members and the management team to drive growth, enhance shareholder value, and bring transformational solutions to patients in need." | tidy 2 | |
26/9/2024 09:17 | Exactly all his buddies going to be loading up on this tiddler...now in with the big boys...$bn! | zen12 | |
26/9/2024 09:15 | Purcell is co-founder and former managing partner of Aisling Capital, a US healthcare investment firm that raised around $1.8 billion since its inception. According to Graft Polymer, his knowledge and global network will be invaluable in expanding the company's presence in both US and European markets.hTTps://www. | tidy 2 | |
26/9/2024 09:14 | Wait this US markets wake up...! | zen12 | |
26/9/2024 09:14 | real news a long way off.. will be back down soon enough | ssrover | |
26/9/2024 08:49 | Tier 1 appointment for sure. Just imagine the connections this guy has - investment banker in his early days plus over 40 years experience in bio sciences. | gah123 | |
26/9/2024 08:26 | CEO Interview on Proactive Investor few minutes ago...https://m.youtub | zen12 | |
26/9/2024 08:18 | Looks like big orders being filled in background? | zen12 | |
26/9/2024 08:15 | An experienced big hitter to do big deals. Watch this space | smackeraim | |
26/9/2024 07:30 | Excellent appointment! | smackeraim | |
26/9/2024 07:19 | Can see a repeat of the 5-7 bags it did before - way too cheap down here | gah123 | |
26/9/2024 07:15 | Yep, global leader in his field, game changer? | zen12 | |
26/9/2024 06:56 | Future multi bagger this one. | bri15 | |
26/9/2024 06:13 | Well the new CEO seems a brilliant choice,this guy has so many contacts in the industry and is also capable of obtaining funds from the private sector to enable GPL to grow massively, think I may have a top up as market should be very favourable of this. | bri15 | |
28/8/2024 11:23 | https://youtu.be/PKL | smackeraim | |
28/8/2024 07:43 | hopefully soon lol. it has drifted away a bit hasn't it. hopefully more news flow into Autumn | smackeraim | |
28/8/2024 06:53 | Who knows but when it goes up it does go up a fair bit | 999rp | |
27/8/2024 07:42 | When's this to start living again | lemonadestand1 | |
21/8/2024 10:51 | Drift over? some decent buying again phew | smackeraim | |
15/8/2024 13:46 | People slowly adding at the .2 support ahead of news | smackeraim | |
12/8/2024 14:19 | Literally says it. "Yifat departs us with our sincere thanks for all she has done during the transitionary period since I became Chairman. She has provided us with invaluable guidance and professionalism."New board appointments are planned to steer the Company as it pursues its mission to innovate in drug delivery solutions. " | smackeraim | |
12/8/2024 14:19 | just part of the restructuring/board changes I'd think. | smackeraim | |
12/8/2024 13:16 | It is unsettling that the CFO has departed so abruptly without a replacement being lined up. There could be a boardroom clash, may be a personality clash since the appointment of new CEO. | kingston78 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions